International Journal of Physical Medicine & Rehabilitation
Open Access

Masayoshi Yamaguchi

Biography

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Visiting Professor in Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (2012–), Visiting Professor in Department of Pathobiology, College of Veterinary Medicine, The University of Missouri-Columbia, MO, USA (2012), Visiting Professor in Department of Foods and Nutrition, The University of Georgia, GA, USA (2011 – 2012), Visiting Professor in Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, GA, USA (2007 – 2011), Professor in Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1993 ~ August 2007), Associate Professor in Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1991~1993), Assistant Professor in School of Pharmaceutical Sciences, University of Shizuoka, Japan (1987~1991), Visiting Assistant Professor in The University of Texas Medical School at Huston, USA (1988), Assistant Professor in Shizuoka College of Pharmacy, Japan (1986~1987); Visiting Assistant Professor in Texas Tech University School of Medicine, USA (1985); Visiting Lecturer in The University of Pennsylvania School of Medicine, USA (1981), Research Associate in Shizuoka College of Pharmacy, Japan (1973 ~ 1986). He received a Ph.D. in Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan). He has completed his B.S. in Pharmaceutical Sciences, Shizuoka, Japan (1971). Dr. Yamaguchi is engaged in the fields of bone and calcium endocrinology and cell calcium signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology.

Research Interest

Calcium endocrinology, bone biology, osteoporosis, prevention by nutritional factor, cell signaling and disorder, diabetes and osteoporosis, lipid metabolism and insulin impairment.